Original research: GWAS meta-analysis of 16 790 patients with Barrett’s oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level(26 July, 2022)
JuliaSchröder,LauraChegwidden,CarloMaj,JanGehlen,JanSpeller,Anne CBöhmer,OlegBorisov,TimoHess,NicoleKreuser,MarinoVenerito,HakanAlakus,AndreaMay,ChristianGerges,ThomasSchmidt,ReneThieme,DominikHeider,Axel MHillmer,JulianReingruber,OrestisLyros,ArneDietrich,AlbrechtHoffmeister,MatthiasMehdorn,FlorianLordick,GertraudStocker,MichaelHohaus,DanielReim,JennisKandler,MichaelaMüller,AlannaEbigbo,ClaudiaFuchs,Christiane JBruns,Arnulf HHölscher,HaukeLang,Peter PGrimminger,DaniDakkak,YogeshVashist,SandraMay,SiegfriedGörg,AndreFranke,DavidEllinghaus,SaraGalavotti,LotharVeits,JosefWeismüller,JensDommermuth,UdoBenner,ThomasRösch,HelmutMessmann,BrigitteSchumacher,HorstNeuhaus,CarstenSchmidt,Thaddäus TWissinowski,Markus MNöthen,Wellcome Trust Case Control Consortium 2 (WTCCC2),Esophageal Adenocarcinoma Genetics Consortium (EAGLE),Barrett's and Esophageal Adenocarcinoma Consortium (BEACON),JingDong,Jue-ShengOng,Matthew FBuas,Aaron PThrift,Thomas LVaughan,IanTomlinson,David CWhiteman,Rebecca ClaireFitzgerald,JanuszJankowski,MichaelVieth,AndreasMayr,PuyaGharahkhani,StuartMacGregor,InesGockel,ClairePalles,JohannesSchumacher
Commentaries